Sarcomatoid renal cell carcinoma: Biology and treatment advances

被引：52

作者：

El Mouallem, Nemer ^{[1
]}

Smith, Steven C. ^{[2
]}

Paul, Asit K. ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Massey Canc Ctr, VCU Med Ctr, Richmond, VA 23284 USA

[2] Virginia Commonwealth Univ, Dept Pathol, Massey Canc Ctr, VCU Med Ctr, Richmond, VA USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2018年 / 36卷 / 06期

关键词：

Sarcomatoid renal cell carcinoma; Renal cell carcinoma; Nephrectomy; Chemotherapy; Targeted therapy; Immunotherapy; CYTOREDUCTIVE NEPHRECTOMY; INTERNATIONAL SOCIETY; ANTI-PD-L1; ANTIBODY; PD-L1; EXPRESSION; CANCER; TUMORS; CLASSIFICATION; PATHOLOGY; BIOPSY; SAFETY;

D O I：

10.1016/j.urolonc.2017.12.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Sarcomatoid transformation in renal cell carcinoma, so called sacromatoid RCC (sRCC), is associated with an aggressive behavior and a poor prognosis. Current therapeutic approaches are largely ineffective. Recent studies looking into the genomic and molecular characterization of sRCCs have provided insights into the biology and pathogenesis of this entity. These advances in molecular signatures may help development of effective treatment strategies. We herein present a review of recent developments in the pathology, biology, and treatment modalities in sRCC. (C) 2017 Elsevier Inc. All rights reserved.

引用

页码：265 / 271

页数：7

共 61 条

[21]

Haas NB, 2016, 2016 AM SOC CLIN ONC

[22] Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study [J].

Hanna, Nawar ;

Sun, Maxine ;

Meyer, Christian P. ;

Nguyen, Paul L. ;

Pal, Sumanta K. ;

Chang, Steven L. ;

de Velasco, Guillermo ;

Quoc-Dien Trinh ;

Choueiri, Toni K. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (27) :3267-+

[23] Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium [J].

Heng, Daniel Y. C. ;

Wells, J. Connor ;

Rini, Brian I. ;

Beuselinck, Benoit ;

Lee, Jae-Lyun ;

Knox, Jennifer J. ;

Bjarnason, Georg A. ;

Pal, Sumanta Kumar ;

Kollmannsberger, Christian K. ;

Yuasa, Takeshi ;

Srinivas, Sandy ;

Donskov, Frede ;

Bamias, Aristotelis ;

Wood, Lori A. ;

Ernst, D. Scott ;

Agarwal, Neeraj ;

Vaishampayan, Ulka N. ;

Rha, Sun Young ;

Kim, Jenny J. ;

Choueiri, Toni K. .

EUROPEAN UROLOGY, 2014, 66 (04) :704-710

[24] Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients [J].

Herbst, Roy S. ;

Soria, Jean-Charles ;

Kowanetz, Marcin ;

Fine, Gregg D. ;

Hamid, Omid ;

Gordon, Michael S. ;

Sosman, Jeffery A. ;

McDermott, David F. ;

Powderly, John D. ;

Gettinger, Scott N. ;

Kohrt, Holbrook E. K. ;

Horn, Leora ;

Lawrence, Donald P. ;

Rost, Sandra ;

Leabman, Maya ;

Xiao, Yuanyuan ;

Mokatrin, Ahmad ;

Koeppen, Hartmut ;

Hegde, Priti S. ;

Mellman, Ira ;

Chen, Daniel S. ;

Hodi, F. Stephen .

NATURE, 2014, 515 (7528) :563-+

[25] Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre [J].

Jonasch, Eric ;

Lal, Lincy S. ;

Atkinson, Bradley J. ;

Byfield, Stacey DaCosta ;

Miller, Lesley Ann ;

Pagliaro, Lance C. ;

Feng, Chun ;

Tannir, Nizar M. .

BJU INTERNATIONAL, 2011, 107 (05) :741-747

[26] PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation [J].

Joseph, Richard W. ;

Millis, Sherri Z. ;

Carballido, Estrella M. ;

Bryant, David ;

Gatalica, Zoran ;

Reddy, Sandeep ;

Bryce, Alan H. ;

Vogelzang, Nicholas J. ;

Stanton, Melissa L. ;

Castle, Erik P. ;

Ho, Thai H. .

CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) :1303-1307

[27]

Keskin SK, 2017, J UROLOGY, V198, P530, DOI 10.1016/j.juro.2017.04.067

[28] Renal Mass Biopsy: Always, Sometimes, or Never? [J].

Kutikov, Alexander ;

Smaldone, Marc C. ;

Uzzo, Robert G. ;

Haifler, Miki ;

Bratslavsky, Gennady ;

Leibovich, Bradley C. .

EUROPEAN UROLOGY, 2016, 70 (03) :403-406

[29] Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma [J].

Kwak, Cheol ;

Park, Yong Hyun ;

Jeong, Chang Wook ;

Jeong, Hyeon ;

Lee, Sang Eun ;

Moon, Kyung Chul ;

Ku, Ja Hyeon .

JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (04) :317-323

[30]

Kyriakopoulos Christos E, 2015, Clin Genitourin Cancer, V13, pe79, DOI 10.1016/j.clgc.2014.08.011

← 1 2 3 4 5 6 7 →